The FDA is changing how it allows COVID-19 antibody testing to be implemented during the coronavirus pandemic, toughening up its oversight after criticisms that unreliable serological tests were being released. Antibody tests aren’t designed to identify whether a patient is currently infected with COVID-19, but instead show whether they have had it recently. As such, they’re considered an important tool …
The FDA is changing how it allows COVID-19 antibody testing to be implemented during the coronavirus pandemic, toughening up its oversight after criticisms that unreliable serological tests were being released. Antibody tests aren’t designed to identify whether a patient is currently infected with COVID-19, but instead show whether they have had it recently. As such, they’re considered an important tool …
Share this Article
Recommended